1. Introduction

Affirmative action through genomics refers to the use of genomic science, genetic information, population genetics, and related biomedical research in designing, implementing, or evaluating policies intended to reduce disadvantage and promote equality.

It lies at the intersection of constitutional law, equality and anti-discrimination law, bioethics, privacy, medical genetics, and public policy.

The central legal question is:

Can genetic or genomic information be used to identify disadvantaged groups, allocate opportunities, improve healthcare access, or justify affirmative-action measures without creating new forms of discrimination?

The answer depends on the purpose, the quality of the scientific evidence, the legal framework, and the safeguards protecting individuals and communities.

An important distinction must be made at the outset: genomics can help identify health disparities and improve the representation of underrepresented populations in research, but genetic ancestry is not equivalent to caste, race, ethnicity, social disadvantage, or an individual's personal identity.

2. Meaning and scope

A. Genomic equity in healthcare

Using genomic research to ensure that diagnostic tests, precision medicines, and genetic screening are suitable for populations historically underrepresented in biomedical studies.

B. Affirmative action in genomic research

Recruiting historically underrepresented populations, funding research on neglected diseases, and making genetic testing more accessible to underserved communities.

C. Genomic data in equality policy

Studying whether genetic screening, diagnostic algorithms, or precision-medicine programmes produce unequal outcomes across populations.

D. Genomics as a selection criterion

Using an individual's genetic profile to allocate education, employment, insurance, public benefits, or other opportunities. This raises substantially greater legal and ethical risks.

The first three applications may support equality when appropriately designed. The fourth requires particular scrutiny because genetic information can become a basis for exclusion, profiling, or coercion.

3. Constitutional and legal foundations

A. India: affirmative action and genomic equality

In India, affirmative action is principally associated with constitutional reservations, special measures for disadvantaged communities, and substantive equality. Genomic information does not independently establish eligibility for reservation.

The relevant constitutional provisions include:

Core principle: India's constitutional reservation framework is grounded in legally recognised social disadvantage, backwardness, representation, and the particular constitutional provision involved. A DNA test cannot substitute for the legal criteria governing caste status or reservation eligibility.

Genomics may nevertheless help identify unmet medical needs, improve healthcare access in underserved communities, and evaluate whether public health services reach disadvantaged populations.

B. International human-rights framework

Several international instruments provide a useful framework for evaluating genomic affirmative action:

Universal Declaration of Human Rights, Articles 1, 2 and 7: dignity, non-discrimination and equality before the law.

International Covenant on Economic, Social and Cultural Rights, Article 12: the right to the highest attainable standard of health.

International Convention on the Elimination of All Forms of Racial Discrimination, Article 1(4): certain special measures designed to secure adequate advancement for protected racial or ethnic groups are permitted, subject to the Convention's conditions.

UNESCO Universal Declaration on the Human Genome and Human Rights (1997): human dignity, non-discrimination based on genetic characteristics, and ethical responsibilities in genetic research.

These principles support using genomic science to reduce exclusion, but not treating genetic differences as evidence that one group is biologically superior or inferior.

4. Major case laws and their application

A necessary qualification: there is no established line of reported Indian judgments creating a doctrine of affirmative action allocated by DNA or genetic ancestry. The following cases are relevant by analogy because they govern reservation, equality, privacy, biological information, or genetic discrimination. Their holdings should not be mistaken for direct rulings on genomic affirmative action.

Case 1: State of Kerala v. N. M. Thomas (1976)

Supreme Court of India · AIR 1976 SC 490

Principle: Equality may require substantive measures to address entrenched disadvantage rather than merely identical treatment for everyone.

The judgment is an important authority in the development of Indian affirmative-action jurisprudence. The Court examined measures benefiting members of Scheduled Castes and Scheduled Tribes in the context of public employment.

Application to genomics: If genomic research reveals that particular underserved populations lack access to genetic counselling, diagnosis, or life-saving therapies, the State may consider targeted remedial healthcare measures under a valid legal framework.

However, the judgment does not authorise the State to classify citizens by DNA or to replace constitutional reservation criteria with genetic ancestry.

Case 2: Indra Sawhney v. Union of India (1992)

Supreme Court of India · 1992 Supp (3) SCC 217

Principle: Reservation must comply with the constitutional framework governing backward classes and public employment.

The nine-judge Bench examined the Mandal Commission reservations, the meaning of backward classes, the exclusion of the creamy layer in the relevant OBC context, and limitations on reservation.

The case remains a central authority on Article 16(4), although subsequent constitutional amendments and judgments have developed aspects of reservation law.

Application to genomics: Genetic ancestry is not a substitute for social and educational backwardness or inadequate representation. A policy that grants public employment reservations based only on a DNA-defined population would face serious constitutional objections.

Genomic evidence might inform a separate public-health intervention, but that is legally different from establishing eligibility for an employment quota.

Case 3: M. Nagaraj v. Union of India (2006)

Supreme Court of India · (2006) 8 SCC 212

Principle: Constitutional reservation in promotion for SCs/STs is subject to constitutional conditions and evidentiary requirements.

The Court considered constitutional amendments concerning reservation in promotion and the framework governing their implementation. Its treatment of quantifiable data and reservation requirements was subsequently clarified in later jurisprudence, including Jarnail Singh.

Application to genomics: Scientific evidence should not be confused with legally relevant evidence. Even reliable genomic data cannot, by itself, establish inadequate representation in public services or satisfy the other requirements applicable to a reservation policy.

Case 4: Jarnail Singh v. Lachhmi Narain Gupta (2018)

Supreme Court of India · (2018) 10 SCC 396

Principle: The Court modified aspects of the Nagaraj framework, including holding that the State need not collect quantifiable data to establish the backwardness of SCs and STs for reservation in promotion. Other constitutional requirements remain relevant.

Application to genomics: A State cannot assume that a genetic study is a universal substitute for the evidence and legal standards required in reservation policy. The relevant inquiry depends on the particular constitutional provision and the controlling judgments.

These Indian reservation cases establish an important boundary: affirmative action must be justified through the constitutionally relevant form of disadvantage, not merely through biological classification.

Case 5: Justice K. S. Puttaswamy (Retd.) v. Union of India (2017)

Supreme Court of India · (2017) 10 SCC 1

Principle: The right to privacy is a fundamental right protected by the Constitution.

The nine-judge Bench recognised privacy as an intrinsic component of liberty, dignity, and personal autonomy under the Constitution. The judgment provides a foundational framework for assessing the collection and use of intimate personal information.

Application to genomics: Genetic data can reveal information about an individual's identity, health risks, biological relatives, and potentially other sensitive characteristics. A public authority establishing a genomic database for affirmative-action research must therefore consider the legal basis for collection, purpose limitation, confidentiality, and proportionality.

A programme intended to improve healthcare access cannot automatically justify compulsory DNA collection from a caste, tribal, ethnic, or economically disadvantaged community.

The privacy framework is particularly important where participation in genetic testing is linked to access to government benefits.

Case 6: Sharda v. Dharmpal (2003)

Supreme Court of India · (2003) 4 SCC 493

Principle: Courts may, in appropriate circumstances, order medical examinations in matrimonial proceedings, but such orders must be assessed within the relevant legal framework.

The judgment concerns medical examination rather than affirmative action. It is relevant to the broader question of when the law may permit intrusive examinations despite an individual's objection.

Application to genomics: A government cannot assume that the existence of a scientifically useful DNA test gives it unrestricted authority to compel testing. The legal basis, necessity, purpose, and applicable safeguards matter.

Case 7: Bhabani Prasad Jena v. Convenor Secretary, Orissa State Commission for Women (2010)

Supreme Court of India · (2010) 8 SCC 633

Principle: DNA testing should not be ordered routinely in paternity disputes; the Court must examine whether it is genuinely necessary and balance competing interests.

The judgment recognises that scientific accuracy does not eliminate questions of privacy, dignity, and potential harm.

Application to genomics: The State should not treat genomic testing as an automatic prerequisite for accessing affirmative-action or public-health programmes. Where the objective can be achieved through less intrusive evidence, compulsory genetic testing requires a particularly strong justification.

These DNA-testing judgments do not directly decide affirmative-action policy. Their relevance is the constitutional and legal caution they provide against unnecessary biological intrusion.

Case 8: Students for Fair Admissions, Inc. v. President and Fellows of Harvard College (2023)

Supreme Court of the United States · 600 U.S. 181 (2023)

Principle: The US Supreme Court held that the challenged race-conscious admissions programmes at Harvard and the University of North Carolina violated the Equal Protection Clause and, in Harvard's case, Title VI of the Civil Rights Act.

The Court scrutinised the programmes' objectives and the use of racial classifications in admissions. The judgment substantially changed the legal position for race-conscious university admissions in the United States.

LII / Legal Information Institute

Application to genomic affirmative action: This case illustrates why the legal justification for a selection criterion matters. If using race as an admissions factor is subject to demanding constitutional scrutiny, using genetic ancestry as a proxy for race or disadvantage would raise additional concerns about scientific validity, privacy, and discriminatory classification.

However, the decision does not prohibit all diversity initiatives, all targeted health programmes, or every policy designed to address socioeconomic disadvantage. Its direct holding concerns the particular admissions programmes and the applicable US legal framework.

Case 9: Grutter v. Bollinger (2003)

Supreme Court of the United States · 539 U.S. 306 (2003)

Principle: The Court upheld the University of Michigan Law School's admissions programme under the legal framework then applicable to race-conscious higher education admissions.

The judgment historically supported a form of individualised admissions consideration rather than a rigid racial quota. Its approach was subsequently overtaken in significant part by Students for Fair Admissions in 2023.

Application to genomics: The case is useful for understanding the historical distinction between broad diversity objectives and rigid group classifications. It does not establish authority to use genetic ancestry as an admissions criterion.

Case 10: Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

Supreme Court of the United States · 569 U.S. 576 (2013)

Principle: Naturally occurring DNA segments are not patent-eligible merely because they have been isolated, although synthetically created cDNA may be patent-eligible subject to the Court's reasoning.

The judgment concerns patent eligibility, not affirmative action or genetic discrimination.

Application to genomic equity: It provides background for debates about access to genetic testing, the control of genomic technologies, and the relationship between biotechnology and public benefit. Patent law alone, however, does not guarantee affordable testing or equitable distribution of genomic healthcare.

5. Genetic discrimination and the law

A distinction is necessary between laws governing the use of genetic information and constitutional doctrines governing affirmative action.

United States: Genetic Information Nondiscrimination Act (GINA), 2008

GINA provides a direct statutory example of legal protection against genetic discrimination.

Under Title II, covered employers generally cannot use genetic information in decisions concerning hiring, dismissal, pay, promotion, or other employment conditions. The Act also restricts the acquisition and disclosure of genetic information. Title I addresses specified health-insurance practices.

U.S. Equal Employment Opportunity Commission

+1

Consider this hypothetical:

A company rejects an applicant after learning that genetic testing indicates an elevated risk of developing a serious illness in the future.

Under the applicable GINA employment provisions, that decision would generally be prohibited. The employer cannot treat a predicted genetic risk as a substitute for evaluating the applicant's present ability to perform the job.

The Act is not a general affirmative-action statute. It illustrates the separate principle that genetic characteristics should not become a basis for unjustified disadvantage.

India: privacy and personal-data protection

India does not have an exact equivalent of GINA that comprehensively prohibits genetic discrimination across all employment and insurance contexts.

The following legal sources are relevant:

Article 21 and Puttaswamy: constitutional privacy and personal autonomy.

Digital Personal Data Protection Act, 2023: a statutory framework governing digital personal data, subject to its provisions, commencement, and applicable exemptions. The Act's general framework should not be mistaken for a comprehensive genetic-discrimination prohibition.

India Code

+1

Applicable medical ethics, clinical-research rules, and sector-specific laws: these may impose additional duties depending on the activity and institution.

A legal assessment of a particular genomic programme must examine the law actually applicable to that programme, including any relevant rules and commencement notifications, rather than assume that all genetic data automatically falls under a single specialised statutory regime.

6. Scientific foundation: Why genomics cannot simply replace social disadvantage

Genomics studies DNA and how genetic variation relates to biological characteristics. Affirmative action, by contrast, generally addresses disadvantages created or sustained by social, historical, economic, or institutional conditions.

These concepts overlap in some healthcare settings, but they are not interchangeable.

The National Academies of Sciences, Engineering, and Medicine, in its 2023 report Using Population Descriptors in Genetics and Genomics Research, recommends that researchers should not use race as a proxy for human genetic variation. It also warns against treating populations as biologically uniform, fixed, or hierarchical categories.

National Academies

+1

Consider three hypothetical situations:

Potentially justified

Scenario A: Improving access to genetic testing

A public hospital finds that a rural, underserved population has poor access to screening for a medically relevant inherited condition. It provides mobile testing, counselling, and subsidised treatment based on medical need and barriers to access.

Legal assessment: This is a plausible equality-oriented healthcare intervention, provided it complies with applicable law, consent requirements, and appropriate clinical standards.

Requires scrutiny

Scenario B: Genomic data determines priority for treatment

A government allocates scarce treatments using genetic markers associated with the likelihood of treatment response.

Legal assessment: A clinically validated marker may be relevant to treatment efficacy, but the decision must also consider fairness, medical necessity, access, disability rights, and whether the allocation method unjustifiably excludes patients.

High legal risk

Scenario C: DNA determines caste-based reservation

A university requires applicants to undergo ancestry testing and uses their genetic results to determine whether they qualify for a caste-based reserved seat.

Legal assessment: This would raise serious questions under constitutional equality, privacy, and the legally established rules for determining reservation eligibility. Genetic ancestry is not a reliable substitute for the legally relevant social category.

7. Governance doctrine: A legal framework for genomic affirmative action

A responsible genomic affirmative-action programme should satisfy the following requirements.

1. Constitutional legality

The programme must have a valid legal basis and pursue a legitimate objective. If it involves a reservation or classification, it must satisfy the constitutional requirements applicable to that specific measure.

2. Scientific validity

Genetic markers must be validated for their intended purpose. Findings from one ancestry group must not automatically be assumed to apply to all other populations.

3. Privacy and informed consent

Collect only the genetic data reasonably necessary for the programme. Explain the purpose of testing, who will access the information, how long it will be retained, and what risks are involved.

4. Non-discrimination

Genetic ancestry must not be used as a proxy for intelligence, social worth, caste status, employment suitability, or presumed moral character.

5. Transparency and accountability

Institutions should document the criteria used, validate the programme's effects, investigate complaints, and provide an accessible process for challenging erroneous or discriminatory decisions.

6. Periodic review

Review the programme as scientific evidence, public needs, and applicable law change. An intervention should be modified or discontinued if it produces unjustified exclusion or no longer serves its intended purpose.

These are proposed governance safeguards, not a claim that every jurisdiction has enacted each one as a standalone legal requirement.

8. Liability and accountability

Different actors may face different legal consequences depending on their conduct and the applicable jurisdiction.

Liability is not automatic merely because a genomic programme produces unequal outcomes. The facts, legal duty, causal connection, applicable defence, and available remedy must be examined.

9. Important legal distinctions

10. Conclusion

Affirmative action through genomics is best understood as a developing field of equality policy and genomic governance, rather than an established legal doctrine permitting benefits to be allocated by DNA.

The Indian cases N. M. Thomas, Indra Sawhney, M. Nagaraj, and Jarnail Singh provide the constitutional framework for substantive equality and reservation. Puttaswamy, Sharda, and Bhabani Prasad Jena inform the privacy and bodily-intrusion questions. The US cases Students for Fair Admissions and Grutter illustrate how affirmative-action rules depend on the jurisdiction and the precise policy being challenged. GINA supplies a separate statutory model for protection against genetic discrimination.

The central legal distinction is this: genomics may help identify health needs and improve access to beneficial services, but genetic ancestry should not be treated as a substitute for social disadvantage, legally recognised group membership, or constitutionally required evidence.

For further research, the most useful primary materials are the Supreme Court of India judgments on reservation and privacy, the official text of the Digital Personal Data Protection Act, 2023, the US Supreme Court opinion in Students for Fair Admissions, and the National Academies' 2023 genomic population-descriptor report. The precise legal outcome of any proposed programme will depend on its design, purpose, jurisdiction, and current applicable law.